https://www.cureus.com/articles/473502
Drug Utilization and Safety Profile of Intravenous Iron Isomaltoside 1000 in Cancer Patients With...
Background: Iron deficiency anemia (IDA) is a persistent complication in cancer patients and may result from chronic inflammation, poor nutritional intake, and...
safety profileintravenous ironcancer patientsdrugutilization
https://www.grandviewresearch.com/press-release/global-intravenous-iron-drugs-market
Intravenous Iron Drugs Market To Reach $5.62Bn By 2030
The global intravenous iron drugs market size is expected to reach USD 5.62 billion by 2030, expanding at a CAGR of 9.1% from 2025 to 2030, according to a new...
intravenous irondrugs marketreach